GILD is moving with the news these days but the risk vs. reward is looking good, even after coming of the Double Top. I would love to see it bounce of the trend line and buy around $71 for a easy swing to an $80 target. Any good news can make this happen sooner than later. Regardless of the outcome of the trials, big pharma is one of the safest spots to invest right now in my opinion. Take this all with a grain of salt and do your own homework. I honestly have no idea what I'm talking about but just throwing up some ideas to look back at later.